BREANNE HESSELTINE: Open Payments
NPI 1235708975 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,336 in 49 payments from 14 companies in 2025. Trend: 2023 $239 · 2024 $870 · 2025 $1,336
Food & beverage: $1,336
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 7 | $245 |
| Incyte Corporation | 10 | $189 |
| Lilly USA, LLC | 4 | $170 |
| Galderma Laboratories, L.P. | 5 | $156 |
| GENZYME CORPORATION | 3 | $141 |
| ABBVIE INC. | 5 | $85 |
| LEO Pharma Inc. | 3 | $79 |
| UCB, Inc. | 2 | $64 |
| Botanix SB Inc | 3 | $63 |
| Amgen Inc. | 2 | $46 |
Products named: VTAMA, OPZELURA, NEMLUVIO, DUPIXENT, EBGLYSS, SKYRIZI, Bimzelx, SOFDRA.
Industry payments across CA — which companies pay providers there.
